Screening and nursing management of gestational diabetes in Ghana: Evidence-based recommendations. [PDF]
Mensah GP +2 more
europepmc +1 more source
Aims This real‐world pharmacovigilance study utilizes FDA Adverse Event Reporting System (FAERS) data (2004–2024) to characterize age‐related disparities in hydroxychloroquine (HCQ)‐associated adverse events (AEs), addressing gaps in age‐stratified risk assessment. Methods Disproportionality analysis (reporting odds ratios, RORs) and parametric Weibull
Guanghan Sun +4 more
wiley +1 more source
Identifying barriers to nursing management of postoperative stress hyperglycaemia in non-diabetic patients: a TDF-guided qualitative study in a Chinese tertiary hospital. [PDF]
Wang N +5 more
europepmc +1 more source
Retracted: Design and Implementation of Hospital Automatic Nursing Management Information System Based on Computer Information Technology. [PDF]
Methods In Medicine CAM.
europepmc +1 more source
Aims The aim of this study was to introduce a new assessment method for pharmacy students' real‐life competence in reviewing medications after obligatory advanced‐level practical internship in Finland. Methods The new medication review (MR) competence assessment method consisted of (1) a self‐assessment by pharmacy students and (2) a performance ...
Katja Leiman +5 more
wiley +1 more source
Nursing Management in Pediatric Intensive Care in South Asia. [PDF]
Hirao D +4 more
europepmc +1 more source
Background Information on mitoxantrone pharmacokinetics in children is lacking and reduced dosing regimens applied to infants are supported by limited scientific rationale. The current study characterized mitoxantrone pharmacokinetics in a childhood acute myeloid leukaemia patient population and provides a data‐informed assessment of dosing.
Andrew M. Brandon +13 more
wiley +1 more source
The impact of changes to RS-1 on nursing management: a new approach to psychosocial risks in nursing. [PDF]
Dos Santos SVM, Resck ZMR, Silva VC.
europepmc +1 more source
Intravenous lanadelumab for the treatment of moderately ill COVID‐19 patients
Aims Kallikrein‐kinin system (KKS) dysregulation is hypothesized to play a pathogenetic role in COVID‐19‐associated pulmonary oedema. To investigate the efficacy and safety of intravenous lanadelumab, a monoclonal antibody that inhibits plasma kallikrein, in COVID‐19, we conducted a phase 2, open‐label, randomized‐controlled, proof‐of‐concept ...
Job J. Engel +12 more
wiley +1 more source
Nurses' knowledge, attitudes, and practices regarding deep vein thrombosis and the nursing management. [PDF]
Hu S, Huang J, Wang H, Wang Y.
europepmc +1 more source

